Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR183 | P32249 | 6/20 | 1.00 |
| ▸ | NPC1L1 | Q9UHC9 | 6/20 | 1.00 |
| ▸ | RORC | P51449 | 4/20 | 1.00 |
| ▸ | RORA | P35398 | 3/20 | 1.00 |
| ▸ | OSBP | P22059 | 4/20 | 0.80 |
| ▸ | OSBP2 | Q969R2 | 2/20 | 0.80 |
| ▸ | USP2 | O75604 | 2/20 | 0.69 |
| ▸ | LMNA | P02545 | 1/20 | 0.69 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.69 |
| ▸ | CYP46A1 | Q9Y6A2 | 1/20 | 0.69 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.67 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.58 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.58 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15083017 | 1.00 | GPR183 (1.00) | GPR183NPC1L1RORCRORAOSBP | |
| SCHEMBL2530829 | 1.00 | GPR183 (1.00) | GPR183NPC1L1RORCRORAOSBP | |
| SCHEMBL532560 | 1.00 | GPR183 (1.00) | GPR183NPC1L1RORCRORAOSBP | |
| SCHEMBL289219 | 1.00 | GPR183 (1.00) | GPR183NPC1L1RORCRORAOSBP | |
| SCHEMBL6392982 | 1.00 | GPR183 (1.00) | GPR183NPC1L1RORCRORAOSBP | |
| SCHEMBL23810015 | 1.00 | GPR183 (1.00) | GPR183NPC1L1RORCRORAOSBP | |
| SCHEMBL21617323 | 1.00 | GPR183 (1.00) | GPR183NPC1L1RORCRORAOSBP | |
| SCHEMBL22959572 | 1.00 | GPR183 (1.00) | GPR183NPC1L1RORCRORAOSBP | |
| SCHEMBL22959500 | 1.00 | GPR183 (1.00) | GPR183NPC1L1RORCRORAOSBP | |
| SCHEMBL6389457 | 1.00 | GPR183 (1.00) | GPR183NPC1L1RORCRORAOSBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 561 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120000614-A | Composite lipid nanoparticle containing cryoprotectant and preparation method and application thereof | 中国科学院化学研究所 | 2025-05-16 | — | — | CN | claimed |
| EP-3554254-B1 | COMPOSITIONS AND METHODS THAT MODULATE BACTERIA IN A COMPANION ANIMAL | NESTLE SA (CH) | 2025-05-07 | — | — | EP | claimed |
| CN-119912352-A | Fluoro lipid nano-particles and preparation method and application thereof | 中国科学院化学研究所 | 2025-05-02 | — | — | CN | claimed |
| CN-118338907-A | Lipid Nanoparticle (LNP) compositions and methods of using the same | 宾夕法尼亚大学董事会 | 2024-07-12 | — | — | CN | claimed |
| WO-2024109612-A1 | METHOD FOR PREPARING LIPID NANOPARTICLE FOR EFFICIENTLY DELIVERING NUCLEIC ACID DRUG AND USE THEREOF | 中国科学院化学研究所 | 2024-05-30 | — | — | WO | claimed |
| CN-118059061-A | Preparation method and application of lipid nanoparticle for efficiently delivering nucleic acid drug | 中国科学院化学研究所 | 2024-05-24 | — | — | CN | claimed |
| CN-118045169-A | Lipid-charged molecule conjugate, inhalable lipid nanoparticle, and preparation method and application thereof | 中国科学院化学研究所 | 2024-05-17 | — | — | CN | claimed |
| US-20240142475-A1 | COMPOSITIONS AND METHODS FOR THE DETECTION OF TUBERCULOSIS | WASHINGTON UNIVERSITY | 2024-05-02 | — | — | US | claimed |
| WO-2024078193-A1 | LIPID NANOPARTICLE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 中国科学院化学研究所 | 2024-04-18 | — | — | WO | claimed |
| WO-2023215498-A2 | COMPOSITIONS AND METHODS FOR CD28 ANTAGONISM | MODERNATX, INC. (US) | 2023-11-09 | — | — | WO | claimed |
| EP-0648842-B1 | Truncated human cholesterol 7alpha-hydroxylase, method of production and use thereof | UNIV NORTHEASTERN OHIO (US) | 2003-01-08 | — | — | EP | claimed |
| EP-1239848-A2 | COMPOSITIONS AND METHODS FOR MODULATING HDL CHOLESTEROL AND TRIGLYCERIDE LEVELS | University of British Columbia (CA) | 2002-09-18 | — | — | EP | claimed |
| JP-2001509165-A | — | — | 2001-07-10 | — | — | JP | claimed |
| WO-2001015676-A2 | COMPOSITIONS AND METHODS FOR MODULATING HDL CHOLESTEROL AND TRIGLYCERIDE LEVELS | UNIVERSITY OF BRITISH COLUMBIA (CA) | 2001-03-08 | — | — | WO | claimed |
| US-6184215-B1 | TOPICALLY APPLYING TO SKIN A HYDROXYCHOLESTEROL TO ACTIVATE LIVER-BASED X-ACTIVATED RECEPTOR ALPHA (LXRA) | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2001-02-06 | — | — | US | claimed |
| WO-2000049992-A2 | USE OF FXR, PPARα AND LXRα ACTIVATORS TO TREAT ACNE/ACNEIFORM CONDITIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-08-31 | — | — | WO | claimed |
| EP-1019059-A1 | USE OF FXR, PPARalpha AND LXRalpha ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-07-19 | — | — | EP | claimed |
| WO-1998032444-A1 | USE OF FXR, PPARα AND LXRα ACTIVATORS TO RESTORE BARRIER FUNCTION, PROMOTE EPIDERMAL DIFFERENTIATION AND INHIBIT PROLIFERATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-07-30 | — | — | WO | claimed |
| US-5677159-A | TRUNCATED; CATALYTICALLY ACTIVE | NORTHEASTERN OHIO UNIVERSITY (US) | 1997-10-14 | — | — | US | claimed |
| EP-0648842-A2 | Truncated human cholesterol 7alpha-hydroxylase, method of production and use thereof | Northeastern Ohio Universities (US) | 1995-04-19 | — | — | EP | claimed |